Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (61-70 of 243) with videos related to

Pageof 25
Sort By:
Cancer|November 5, 2005
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing miceBenjamin Ory, Marie-Françoise Heymann, Akira Kamijo, et al.
Frontiers in Medicine|December 13, 2018
Osteoprotegerin Induces CD34<sup>+</sup> Differentiation in Endothelial Progenitor CellsCatherine Boisson-Vidal, Zahia Benslimane-Ahmim, Anna Lokajczyk, et al.
Molecules (Basel, Switzerland)|March 10, 2016
Anti-Metastatic Properties of a Marine Bacterial Exopolysaccharide-Based Derivative Designed to Mimic GlycosaminoglycansDominique Heymann, Carmen Ruiz-Velasco, Julie Chesneau, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 11, 2008
Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorptionBénédicte Brounais, Carmen Ruiz, Julie Rousseau, et al.
International Journal of Oncology|December 6, 2005
RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cellsYohann Wittrant, François Lamoureux, Kanji Mori, et al.
Journal of Cellular Physiology|April 4, 2017
Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblastsJulie Talbot, Régis Brion, Audrey Lamora, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Proteoglycans and osteolysisMarc Baud'Huin, Céline Charrier, Gwenola Bougras, et al.
The Journal of Biological Chemistry|September 18, 2009
Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survivalMarc Baud'huin, Laurence Duplomb, Stéphane Téletchéa, et al.
Oncotarget|May 28, 2015
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesAudrey Lamora, Mathilde Mullard, Jérôme Amiaud, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Murine Models of Bone SarcomasCamille Jacques, Nathalie Renema, Benjamin Ory, et al.
Pageof 25

Showing results (61-70 of 243) with videos related to

Sort By:
Pageof 25
Cancer|November 5, 2005
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing miceBenjamin Ory, Marie-Françoise Heymann, Akira Kamijo, et al.
Frontiers in Medicine|December 13, 2018
Osteoprotegerin Induces CD34<sup>+</sup> Differentiation in Endothelial Progenitor CellsCatherine Boisson-Vidal, Zahia Benslimane-Ahmim, Anna Lokajczyk, et al.
Molecules (Basel, Switzerland)|March 10, 2016
Anti-Metastatic Properties of a Marine Bacterial Exopolysaccharide-Based Derivative Designed to Mimic GlycosaminoglycansDominique Heymann, Carmen Ruiz-Velasco, Julie Chesneau, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 11, 2008
Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorptionBénédicte Brounais, Carmen Ruiz, Julie Rousseau, et al.
International Journal of Oncology|December 6, 2005
RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cellsYohann Wittrant, François Lamoureux, Kanji Mori, et al.
Journal of Cellular Physiology|April 4, 2017
Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblastsJulie Talbot, Régis Brion, Audrey Lamora, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Proteoglycans and osteolysisMarc Baud'Huin, Céline Charrier, Gwenola Bougras, et al.
The Journal of Biological Chemistry|September 18, 2009
Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survivalMarc Baud'huin, Laurence Duplomb, Stéphane Téletchéa, et al.
Oncotarget|May 28, 2015
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesAudrey Lamora, Mathilde Mullard, Jérôme Amiaud, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Murine Models of Bone SarcomasCamille Jacques, Nathalie Renema, Benjamin Ory, et al.
Pageof 25